NEOG Form 4: 19,769 shares acquired; 50,814 options at $6.07
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Neogen (NEOG) filed a Form 4 reporting director equity awards. On 10/23/2025, the reporting person acquired 19,769 shares of common stock at $6.07. Following this, directly held common stock totaled 36,788 shares.
The filing also reports 50,814 stock options granted at an exercise price of $6.07, expiring on 10/23/2035, with 50,814 derivative securities beneficially owned after the transaction. Per the footnote, options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
RODRIGUEZ RAFAEL A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) | 50,814 | $0.00 | -- |
| Grant/Award | Common Stock | 19,769 | $6.07 | $120K |
Holdings After Transaction:
Common Stock (Right to Buy) — 50,814 shares (Direct);
Common Stock — 36,788 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did NEOG's Form 4 disclose?
A director acquired 19,769 common shares at $6.07 and received 50,814 stock options at $6.07, expiring 10/23/2035.
What are the terms of the NEOG stock options reported?
50,814 options with a $6.07 exercise price, expiring on 10/23/2035, with vesting as described in the footnote.
How do the NEOG awards vest?
Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Was the filing made by one or more reporting persons?
Form filed by one reporting person.
What is the ownership form noted for the reported holdings?
Both the common stock and derivative securities are reported as directly owned.